✦ LIBER ✦

Nonpeptide αvβ3 Antagonists: Identification of Potent, Chain-Shortened 7-Oxo RGD Mimetics.

✍ Scribed by Amy E. Zartman; Le T. Duong; Carmen Fernandez-Metzler; George D. Hartman; Chih-Tai Leu; Thomayant Prueksaritanont; Gideon A. Rodan; Sevgi B. Rodan; Mark E. Duggan; Robert S. Meissner

Publisher: John Wiley and Sons
Year: 2005
Weight: 20 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200529159

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

For Abstract see ChemInform Abstract in Full Text.

📜 SIMILAR VOLUMES

Non-peptide αvβ3 Antagonists. Part 4. Po

Non-peptide αvβ3 Antagonists. Part 4. Potent and Orally Bioavailable Chain-Shortened RGD Mimetics.

✍ Paul J. Coleman; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB

Non-Peptide αvβ3 Antagonists: Identifica

Non-Peptide αvβ3 Antagonists: Identification of Potent, Chain-Shortened EGD Mimetics that Incorporate a Central Pyrrolidinone Constraint.

✍ James J. Perkins; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 69 KB

ChemInform Abstract: Non-Peptide αvβ3 An

ChemInform Abstract: Non-Peptide αvβ3 Antagonists. Part 3. Identification of Potent RGD Mimetics Incorporating Novel β-Amino Acids as Aspartic Acid Replacements.

✍ Paul J. Coleman; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB

Non-Peptide αvβ3 Antagonists. Part 5. Id

Non-Peptide αvβ3 Antagonists. Part 5. Identification of Potent RGD Mimetics Incorporating 2-Aryl β-Amino Acids as Aspartic Acid Replacements.

✍ Karen M. Brashear; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 88 KB

Nonpeptide αvβ3 Antagonists. Part 10. In

Nonpeptide αvβ3 Antagonists. Part 10. In vitro and in vivo Evaluation of a Potent 7-Methyl Substituted Tetrahydro-[1,8]naphthyridine Derivatives.

✍ Michael J. Breslin; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 27 KB 👁 1 views